<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugRecordsOutput><serviceExecutionTime>409</serviceExecutionTime><Drug id="44698"><DrugName>diphtheria, tetanus, pertussis, polio vaccine (1), Sanofi Pasteur/Merck &amp; Co</DrugName><DrugNamesKey><Name id="42805308">Repevax</Name><Name id="42923197">Tetraxim</Name></DrugNamesKey><DrugSynonyms><Name><Value>Repevax</Value><Types><Type>Trade Name</Type></Types></Name><Name><Value>Td5, Aventis Pasteur MSD</Value></Name><Name><Value>DTaP + IPV, Aventis Pasteur MSD</Value></Name><Name><Value>TdacpIPV booster vaccine, Aventis Pasteur</Value></Name><Name><Value>diphtheria, tetanus, pertussis, polio vaccine (1), Aventis Pasteur MSD</Value></Name><Name><Value>Tetraxim</Value><Types><Type>Trade Name</Type></Types></Name><Name><Value>diphtheria, tetanus, pertussis, polio vaccine (1), Sanofi Pasteur/Merck &amp; Co</Value></Name></DrugSynonyms><CompanyOriginator id="23408">Sanofi Pasteur MSD</CompanyOriginator><CompaniesPrimary><Company id="22127">Sanofi Pasteur</Company></CompaniesPrimary><CompaniesSecondary><Company id="23408">Sanofi Pasteur MSD</Company></CompaniesSecondary><CrossReferences><SourceEntity id="44698" type="Drug"><TargetEntity id="442769" type="siDrug">TdaP-IPV</TargetEntity></SourceEntity><SourceEntity id="22127" type="Company"><TargetEntity id="5000043854" type="organizationId">Sanofi Pasteur SA</TargetEntity></SourceEntity><SourceEntity id="23408" type="Company"><TargetEntity id="4296729711" type="organizationId">MSD Vaccins SAS</TargetEntity></SourceEntity><SourceEntity id="272" type="ciIndication"><TargetEntity id="A80" type="ICD10"></TargetEntity><TargetEntity id="10036012" type="MEDDRA"></TargetEntity><TargetEntity id="D011051" type="MeSH"></TargetEntity><TargetEntity id="2912" type="ORPHANET"></TargetEntity><TargetEntity id="-250236249" type="omicsDisease"></TargetEntity><TargetEntity id="3005" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="47" type="ciIndication"><TargetEntity id="A37" type="ICD10"></TargetEntity><TargetEntity id="033" type="ICD9"></TargetEntity><TargetEntity id="10034738" type="MEDDRA"></TargetEntity><TargetEntity id="D014917" type="MeSH"></TargetEntity><TargetEntity id="1489" type="ORPHANET"></TargetEntity><TargetEntity id="-320620987" type="omicsDisease"></TargetEntity><TargetEntity id="2337" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="72" type="ciIndication"><TargetEntity id="10043376" type="MEDDRA"></TargetEntity><TargetEntity id="D013742" type="MeSH"></TargetEntity><TargetEntity id="3299" type="ORPHANET"></TargetEntity><TargetEntity id="-687302618" type="omicsDisease"></TargetEntity><TargetEntity id="816" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="81" type="ciIndication"><TargetEntity id="A36" type="ICD10"></TargetEntity><TargetEntity id="10013023" type="MEDDRA"></TargetEntity><TargetEntity id="D004165" type="MeSH"></TargetEntity><TargetEntity id="1679" type="ORPHANET"></TargetEntity><TargetEntity id="-360770994" type="omicsDisease"></TargetEntity><TargetEntity id="3234" type="siCondition"></TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="L">Launched</PhaseHighest><PhaseHighestDetailed><FirstLaunched>Bordetella pertussis infection - Germany - Mar-2002</FirstLaunched><FirstLaunched>Clostridium tetani infection - Germany - Mar-2002</FirstLaunched><FirstLaunched>Corynebacterium diphtheriae infection - Germany - Mar-2002</FirstLaunched><FirstLaunched>Poliovirus infection - Germany - Mar-2002</FirstLaunched></PhaseHighestDetailed><IndicationsPrimary><Indication id="272">Poliovirus infection</Indication><Indication id="47">Bordetella pertussis infection</Indication><Indication id="72">Clostridium tetani infection</Indication><Indication id="81">Corynebacterium diphtheriae infection</Indication></IndicationsPrimary><ActionsSecondary><Action id="12371">Subunit vaccine</Action><Action id="12375">Toxoid vaccine</Action><Action id="12378">Prophylactic vaccine</Action></ActionsSecondary><Technologies><Technology id="596">Injectable formulation</Technology><Technology id="766">Parenteral formulation unspecified</Technology><Technology id="761">Biological therapeutic</Technology><Technology id="67">Antigen</Technology></Technologies><LastModificationDate>2018-04-25T09:43:17.000Z</LastModificationDate><ChangeDateLast>2018-04-26T00:00:00.000Z</ChangeDateLast><AddedDate>2003-04-22T11:57:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;&lt;ulink linkID="22127" linkType="Company"&gt;Sanofi Pasteur&lt;/ulink&gt;  (previously developed by its joint-venture with  &lt;ulink linkID="18077" linkType="Company"&gt;Merck &amp;amp; Co&lt;/ulink&gt;,  &lt;ulink linkID="23408" linkType="Company"&gt;Sanofi Pasteur MSD&lt;/ulink&gt; (formerly Aventis Pasteur MSD)) is developed and launched Repevax, a booster vaccine for the injectable prevention of diphtheria, pertussis, tetanus and polio [&lt;ulink linkID="1205214" linkType="Reference"&gt;1205214&lt;/ulink&gt;], [&lt;ulink linkID="1889108" linkType="Reference"&gt;1889108&lt;/ulink&gt;]. It was approved in Germany in November 2001 and launched there in March 2002 [&lt;ulink linkID="490120" linkType="reference"&gt;490120&lt;/ulink&gt;]. Repevax was approved in the EU in June 2002 [&lt;ulink linkID="486343" linkType="reference"&gt;486343&lt;/ulink&gt;].   In August 2002, the drug was approved in Iceland [&lt;ulink linkID="1452232" linkType="Reference"&gt;1452232&lt;/ulink&gt;]. By May 2003, further European launches were underway [&lt;ulink linkID="490120" linkType="reference"&gt;490120&lt;/ulink&gt;]. In July 2003, the vaccine was granted approval in Ireland [&lt;ulink linkID="1405822" linkType="Reference"&gt;1405822&lt;/ulink&gt;]. In October 2004, Repevax was launched in the UK [&lt;ulink linkID="564117" linkType="Reference"&gt;564117&lt;/ulink&gt;]. In 	February 2007, the product was launched in France [&lt;ulink linkID="1350147" linkType="Reference"&gt;1350147&lt;/ulink&gt;]. In January 2010, the vaccine was launched in Korea as Tetraxim [&lt;ulink linkID="1092523" linkType="Reference"&gt;1092523&lt;/ulink&gt;]. In May 2010, the vaccine was launched in Norway [&lt;ulink linkID="1458718" linkType="Reference"&gt;1458718&lt;/ulink&gt;]. In February 2004, the drug was approved in Estonia [&lt;ulink linkID="1460166" linkType="Reference"&gt;1460166&lt;/ulink&gt;]. In October 2015, the vaccine was approved in Taiwan as Tetraxim [&lt;ulink linkID="1718268" linkType="Reference"&gt;1718268&lt;/ulink&gt;].&lt;/para&gt;&lt;para&gt;It is based on &lt;ulink linkID="30214" linkType="Drug"&gt;Daptacel&lt;/ulink&gt;  antigens plus polio antigens.&lt;/para&gt;&lt;/Summary&gt;</value></Summary><Regulatory><displayLabel>Regulatory</displayLabel><value>&lt;Regulatory&gt;&lt;para&gt;The product was approved in Germany in November 2001 and launched there in March 2002 [&lt;ulink linkID="490120" linkType="reference"&gt;490120&lt;/ulink&gt;]. Repevax was approved in the EU in June 2002 [&lt;ulink linkID="486343" linkType="reference"&gt;486343&lt;/ulink&gt;].   In August 2002, the drug was approved in Iceland [&lt;ulink linkID="1452232" linkType="Reference"&gt;1452232&lt;/ulink&gt;].  In 	October 2002,  the product   was approved in France and was launched in February 2007    [&lt;ulink linkID="1350147" linkType="Reference"&gt;1350147&lt;/ulink&gt;]. By May 2003, further European launches were underway [&lt;ulink linkID="490120" linkType="reference"&gt;490120&lt;/ulink&gt;]. In July 2003, the vaccine was granted approval in Ireland [&lt;ulink linkID="1405822" linkType="Reference"&gt;1405822&lt;/ulink&gt;]. In February 2004, the drug was approved in Estonia [&lt;ulink linkID="1460166" linkType="Reference"&gt;1460166&lt;/ulink&gt;]. In October 2004, Repevax was launched in the UK [&lt;ulink linkID="564117" linkType="Reference"&gt;564117&lt;/ulink&gt;]. In January 2010, the vaccine was launched in Korea as Tetraxim [&lt;ulink linkID="1092523" linkType="Reference"&gt;1092523&lt;/ulink&gt;]. In May 2010, the vaccine was launched in Norway [&lt;ulink linkID="1458718" linkType="Reference"&gt;1458718&lt;/ulink&gt;]. In October 2015, the vaccine was approved in Taiwan as Tetraxim [&lt;ulink linkID="1718268" linkType="Reference"&gt;1718268&lt;/ulink&gt;].&lt;/para&gt;&lt;/Regulatory&gt;</value></Regulatory></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="NO">Norway</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="NO">Norway</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="NO">Norway</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="NO">Norway</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="EU">EU</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="EU">EU</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="EU">EU</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="22127">Sanofi Pasteur</Company><Country id="EU">EU</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="X5">Europe</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="NO">Norway</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="NO">Norway</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="X5">Europe</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="X5">Europe</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="NO">Norway</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="NO">Norway</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="X5">Europe</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="272">Poliovirus infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="23408">Sanofi Pasteur MSD</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="6">Deal Termination/Company Bankruptcy</DiscontinuedReason><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2017-01-01T00:00:00.000Z</StatusDate><Source id="1889108" type="PR"/></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="FR">France</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2002-10-04T00:00:00.000Z</StatusDate><Source id="1350147" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="FR">France</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2002-10-04T00:00:00.000Z</StatusDate><Source id="1350147" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="FR">France</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2002-10-04T00:00:00.000Z</StatusDate><Source id="1350147" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="FR">France</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2002-10-04T00:00:00.000Z</StatusDate><Source id="1350147" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2010-01-01T00:00:00.000Z</StatusDate><Source id="1092523" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2010-01-01T00:00:00.000Z</StatusDate><Source id="1092523" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2010-01-01T00:00:00.000Z</StatusDate><Source id="1092523" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="NO">Norway</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2010-05-15T00:00:00.000Z</StatusDate><Source id="1458718" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="NO">Norway</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2010-05-15T00:00:00.000Z</StatusDate><Source id="1458718" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="FR">France</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2007-02-20T00:00:00.000Z</StatusDate><Source id="1350147" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="FR">France</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2007-02-20T00:00:00.000Z</StatusDate><Source id="1350147" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="FR">France</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2007-02-20T00:00:00.000Z</StatusDate><Source id="1350147" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="FR">France</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2007-02-20T00:00:00.000Z</StatusDate><Source id="1350147" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="NO">Norway</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2010-05-15T00:00:00.000Z</StatusDate><Source id="1458718" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="NO">Norway</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2010-05-15T00:00:00.000Z</StatusDate><Source id="1458718" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="GB">UK</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2004-10-01T00:00:00.000Z</StatusDate><Source id="564117" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="DE">Germany</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2002-03-31T00:00:00.000Z</StatusDate><Source id="490120" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="DE">Germany</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2002-03-31T00:00:00.000Z</StatusDate><Source id="490120" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="DE">Germany</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2002-03-31T00:00:00.000Z</StatusDate><Source id="490120" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="DE">Germany</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2002-03-31T00:00:00.000Z</StatusDate><Source id="490120" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="GB">UK</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2004-10-01T00:00:00.000Z</StatusDate><Source id="564117" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="GB">UK</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2004-10-01T00:00:00.000Z</StatusDate><Source id="564117" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="GB">UK</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2004-10-01T00:00:00.000Z</StatusDate><Source id="564117" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2010-01-01T00:00:00.000Z</StatusDate><Source id="1092523" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IE">Ireland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2003-07-25T00:00:00.000Z</StatusDate><Source id="1405822" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IE">Ireland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2003-07-25T00:00:00.000Z</StatusDate><Source id="1405822" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IE">Ireland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2003-07-25T00:00:00.000Z</StatusDate><Source id="1405822" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IE">Ireland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2003-07-25T00:00:00.000Z</StatusDate><Source id="1405822" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="EU">EU</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2002-06-30T00:00:00.000Z</StatusDate><Source id="486343" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="EU">EU</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2002-06-30T00:00:00.000Z</StatusDate><Source id="486343" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="EU">EU</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2002-06-30T00:00:00.000Z</StatusDate><Source id="486343" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="EU">EU</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2002-06-30T00:00:00.000Z</StatusDate><Source id="486343" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><Source id="1452232" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2002-08-15T00:00:00.000Z</StatusDate><Source id="1452232" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2002-08-15T00:00:00.000Z</StatusDate><Source id="1452232" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="EE">Estonia</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2004-02-06T00:00:00.000Z</StatusDate><Source id="1460166" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="EE">Estonia</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2004-02-06T00:00:00.000Z</StatusDate><Source id="1460166" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="EE">Estonia</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2004-02-06T00:00:00.000Z</StatusDate><Source id="1460166" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="EE">Estonia</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2004-02-06T00:00:00.000Z</StatusDate><Source id="1460166" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2015-10-13T00:00:00.000Z</StatusDate><Source id="1718268" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2015-10-13T00:00:00.000Z</StatusDate><Source id="1718268" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="IS">Iceland</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2002-08-15T00:00:00.000Z</StatusDate><Source id="1452232" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2015-10-13T00:00:00.000Z</StatusDate><Source id="1718268" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="TW">Taiwan</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2015-10-13T00:00:00.000Z</StatusDate><Source id="1718268" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="DE">Germany</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="272">Poliovirus infection</Indication><StatusDate>2001-11-30T00:00:00.000Z</StatusDate><Source id="490120" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="DE">Germany</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="47">Bordetella pertussis infection</Indication><StatusDate>2001-11-30T00:00:00.000Z</StatusDate><Source id="490120" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="DE">Germany</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate>2001-11-30T00:00:00.000Z</StatusDate><Source id="490120" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="23408">Sanofi Pasteur MSD</Company><Country id="DE">Germany</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="81">Corynebacterium diphtheriae infection</Indication><StatusDate>2001-11-30T00:00:00.000Z</StatusDate><Source id="490120" type="CORPORATE"/></DevelopmentStatusHistoric></IDdbDevelopmentStatus><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate></ReasonsForUpdate><PatentFamilies><PatentFamily id="1570235" number="WO-09013313" title="Acellular vaccine."/></PatentFamilies><PatentFamilyCountsByTypes><PatentFamilyCountsByType><Type sortorder="12">Product</Type><Count>1</Count></PatentFamilyCountsByType></PatentFamilyCountsByTypes><PatentFamilyCountsByCompanies><PatentFamilyCountsByCompany><CompanyLink nameDisplay="Sanofi SA" id="1009547"/><CountAsOwner>0</CountAsOwner><CountAsThirdParty>1</CountAsThirdParty><CountTotal>1</CountTotal></PatentFamilyCountsByCompany><PatentFamilyCountsByCompany><CompanyLink nameDisplay="Merck &amp; Co Inc" id="18077"/><CountAsOwner>1</CountAsOwner><CountAsThirdParty>0</CountAsThirdParty><CountTotal>1</CountTotal></PatentFamilyCountsByCompany><PatentFamilyCountsByCompany><CompanyLink nameDisplay="UCB SA" id="20452"/><CountAsOwner>1</CountAsOwner><CountAsThirdParty>0</CountAsThirdParty><CountTotal>1</CountTotal></PatentFamilyCountsByCompany><PatentFamilyCountsByCompany><CompanyLink nameDisplay="Novartis AG" id="23137"/><CountAsOwner>0</CountAsOwner><CountAsThirdParty>1</CountAsThirdParty><CountTotal>1</CountTotal></PatentFamilyCountsByCompany><PatentFamilyCountsByCompany><CompanyLink nameDisplay="GlaxoSmithKline plc" id="28355"/><CountAsOwner>1</CountAsOwner><CountAsThirdParty>1</CountAsThirdParty><CountTotal>2</CountTotal></PatentFamilyCountsByCompany></PatentFamilyCountsByCompanies><hasSWOTs>N</hasSWOTs></Drug></drugRecordsOutput>